REGISTERED
on 15 Mar 2022
Last Applicant/ Owned by
1200 Lenox Drive, Suite 100
Lawrenceville
NJ
08648
Serial Number
90364102 filed on 07th Dec 2020
Registration Number
6669722 registered on 15th Mar 2022
Filing Basis
1. use application currently
Disclaimer
NO DATA
ADARE PHARMA SOLUTIONS
Manufacturing of pharmaceutical and nutritional and dietary formulations, to the specifications of others, used as facilitating agents for tablets, capsules, powders, injectables, suspensions, gels, liquids; Manufacturing services for others of drug delivery products for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic, nutritional or dietary agent; Manufac Read More
Classification Information
Class [040]
Treatment & Processing of Materials Services
Manufacturing of pharmaceutical and nutritional and dietary formulations, to the specifications of others, used as facilitating agents for tablets, capsules, powders, injectables, suspensions, gels, liquids; Manufacturing services for others of drug delivery products for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic, nutritional or dietary agent; Manufacturing services for others of pharmaceutical and dietary compositions for use in veterinary administration forms such as tablets, capsules, suspensions, liquids; Manufacturing services for others of particles with specific particle dimension and narrow particle size distributions containing active ingredients
First Use Date in General
02th Oct 2020
First Use Date in Commerce
02th Oct 2020
Class [042]
Computer & Software Services & Scientific Services
Design and development of pharmaceutical, nutritional and dietary formulations; Research and development of drug delivery formulation used as facilitating agents for pharmaceutical tablets, capsules, powders, injectables, suspensions, gels, liquids; Development of pharmaceutical formulations for veterinary applications; Design and development of preparations in liquid form or solid form for the immediate, controlled, extended, delayed, pulsatile or local release of a therapeutic or dietary agent; Development of particles with defined particle size dimensions and particle size distribution containing active ingredients for pharmaceutical purposes; Technology consultation in the field of pharmaceutical development
First Use Date in General
02th Oct 2020
First Use Date in Commerce
02th Oct 2020
Mark Details
Serial Number
No 90364102
Mark Type
No Service Mark
Attorney Docket Number
No 186380-5004
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.02 -
Plain single line circles
26.01.21 -
Circles that are totally or partially shaded
26.05.02 -
Plain single line triangles
26.05.21 -
Triangles that are completely or partially shaded
26.13.28 -
Miscellaneous designs with overall quadrilateral shape
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Mar 2022 | REGISTERED-PRINCIPAL REGISTER |
| 28th Dec 2021 | PUBLISHED FOR OPPOSITION |
| 28th Dec 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Dec 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 23rd Nov 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 19th Nov 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 18th Nov 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 18th Nov 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 26th May 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 26th May 2021 | NON-FINAL ACTION WRITTEN |